Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma

NCT01968317 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Atypical Hyperplasia
Endometrial Adenocarcinoma

Interventions

DRUG: Megestrol acetate and metformin
DRUG: Megestrol acetate

Sponsor

Xiaojun Chen

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]